ADC Therapeutics: US$325m for ADC royalties
The Lausanne-based biotechnology company has entered into a US$325m financing agreement with healthcare investment firm HealthCare Royalty Partners....
Bayer takes over Vividion
The acquisition strengthens Bayer's oncology and immunology pipeline and secures a revolutionary screening technology for small molecule drugs that...
NeuVasQ Biotechnologies bags €20m in Series A financing
Brussels-Basel VC investor Newton Biocapital led the financing round with a €10m contribution from its Newton Biocapital I fund. Another €10m...
Call for pull incentives to get started
With around 30 international experts in the line-up, the virtual conference discussed the current state of the fight against antimicrobial resistance...
Artios Pharma Ltd raises US-$153m Series C financing
With the Series C investment, the UK-based DNA Damage Response (DDR) specialist’s has raised more than $320m. The oversubscribed current US$153...
EuropaBio lobbies for better Orphan Drug rules
The Orphan Drug Regulation adopted in 2000 should be improved to incentivise even ultra-rare conditions with high unmet medical need, according to...
British drug developer Mission Therapeutics plc earns $20m milestone
In the second major milestone of the companies’ research and preclinical development collaboration, AbbVie has nominated two deubiquitylating enzymes...